Prazosin Hydrochloride

Product NDC
70518-2705
11-digit product format
705182705
Labeler code
70518
Product ID
70518-2705_e997ab1a-d236-7074-e053-2a95a90a8220
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Prazosin Hydrochloride
Dosage form
CAPSULE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA210971
Marketing category
ANDA
Marketing start
2020-04-23
Marketing end
0000-00-00
Substance
PRAZOSIN HYDROCHLORIDE
Active strength
5 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70518-2705PRAZOSIN HYDROCHLORIDE CAPSULE [REMEDYREPACK INC.]10Legacy NDC20250328_18227ac0-f8c2-41a1-931c-cebba89a50a2.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2705-07051827050030 CAPSULE in 1 BLISTER PACK (70518-2705-0) 30 capsule2020-04-230000-00-00NoNoCurrent
70518-2705-17051827050130 CAPSULE in 1 BOTTLE, PLASTIC (70518-2705-1) 30 capsule2022-02-210000-00-00NoNoCurrent
70518-2705-27051827050230 CAPSULE in 1 BOTTLE, PLASTIC (70518-2705-2) 30 capsule2022-09-260000-00-00NoNoCurrent